FDA NDC
ASTAGRAF XL
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0469-0647
- Proprietary name
- ASTAGRAF XL
- Nonproprietary name
- tacrolimus extended-release capsules
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- CAPSULE, COATED, EXTENDED RELEASE
- Strength
- .5 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted tacrolimus extended-release capsules?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.